Published in FASEB J on January 01, 1989
Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol (1991) 2.26
Bradykinin-evoked changes in cytosolic calcium and membrane currents in cultured bovine pulmonary artery endothelial cells. J Physiol (1989) 1.35
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides (2010) 1.15
Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.05
Sensitivity of G-protein involved in endothelin-1-induced Ca2+ influx to pertussis toxin in porcine endothelial cells in situ. Br J Pharmacol (1994) 1.03
The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest (1993) 0.91
On the role of the C-terminus of alpha-calcitonin-gene-related peptide (alpha CGRP). The structure of des-phenylalaninamide37-alpha CGRP and its interaction with the CGRP receptor. Biochem J (1993) 0.86
Homologous desensitization of ATP-mediated elevations in cytoplasmic calcium and prostacyclin release in human endothelial cells does not involve protein kinase C. Biochem J (1990) 0.83
Bradykinin recognizes different molecular forms of the B2 kinin receptor in the presence and absence of guanine nucleotides. Biochem J (1991) 0.76
Role of [Ca(2+)]i and F-actin on mesothelial barrier function. Front Physiol (2014) 0.75
Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers (1991) 3.51
Tests of the helix dipole model for stabilization of alpha-helices. Nature (1987) 3.19
Competitive antagonists of bradykinin. Peptides (1985) 2.91
Calorimetric determination of the enthalpy change for the alpha-helix to coil transition of an alanine peptide in water. Proc Natl Acad Sci U S A (1991) 2.84
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Nature of the charged-group effect on the stability of the C-peptide helix. Proc Natl Acad Sci U S A (1985) 2.09
Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J (1975) 2.07
Urea unfolding of peptide helices as a model for interpreting protein unfolding. Proc Natl Acad Sci U S A (1995) 2.01
Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Lab Invest (1985) 2.01
Kinetics of amide proton exchange in helical peptides of varying chain lengths. Interpretation by the Lifson-Roig equation. Biochemistry (1992) 1.97
Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell (1976) 1.96
The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol (1982) 1.88
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol (2000) 1.88
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet (1995) 1.76
Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells. Tissue Cell (1987) 1.74
Two bradykinin binding sites with picomolar affinities. J Pharmacol Exp Ther (1986) 1.71
Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool. J Clin Microbiol (1991) 1.70
Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol (1993) 1.68
Oral-facial-digital syndrome type VI (Váradi syndrome): further clinical delineation. Am J Med Genet (1990) 1.66
Further studies of the helix dipole model: effects of a free alpha-NH3+ or alpha-COO- group on helix stability. Proteins (1989) 1.63
Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child (2008) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol (1989) 1.55
Direct effects of E coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol (1986) 1.54
Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J (1989) 1.49
Folding of proteins with WD-repeats: comparison of six members of the WD-repeat superfamily to the G protein beta subunit. Biochemistry (1996) 1.48
Methods for microcarrier culture of bovine pulmonary artery endothelial cells avoiding the use of enzymes. Tissue Cell (1980) 1.44
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Isolation and culture of pulmonary artery endothelial cells. Tissue Cell (1978) 1.40
Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells. Am J Physiol (1987) 1.38
Use of pooled formalin-preserved fecal specimens to detect Giardia lamblia. J Clin Microbiol (1991) 1.38
Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.36
Radial artery cannulation. A prospective study in patients undergoing cardiothoracic surgery. Br J Anaesth (1980) 1.34
New synthetic antagonists of bradykinin. Br J Pharmacol (1987) 1.33
Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest (1988) 1.33
Design and synthesis of a peptide having chymotrypsin-like esterase activity. Science (1990) 1.33
Inactivation of bradykinin in the pulmonary circulation. Biochem J (1968) 1.31
Fc and C3b receptors on pulmonary endothelial cells: induction by injury. Science (1981) 1.31
Antinociceptive effects of bradykinin antagonists. Eur J Pharmacol (1987) 1.29
Substance P and analgesia. Nature (1976) 1.27
Absent IgA and deletions of chromosome 18. J Med Genet (1970) 1.26
Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest (1992) 1.25
Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists. Biochim Biophys Acta (1983) 1.25
Microplate assay analysis of the distribution of organophosphate and carbamate resistance in Guatemalan Anopheles albimanus. Bull World Health Organ (1988) 1.24
Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin. J Clin Invest (1991) 1.22
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med (1999) 1.22
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
[3H]Bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci U S A (1981) 1.21
Pulmonary endothelial cells. Fed Proc (1977) 1.20
Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther (1992) 1.18
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Source of iron in neutrophil-mediated killing of endothelial cells. Lab Invest (1987) 1.17
Side-chain interactions in the C-peptide helix: Phe 8 ... His 12+. Biopolymers (1990) 1.16
Submucous cleft palate. Its incidence, natural history, and indications for treatment. Plast Reconstr Surg (1972) 1.15
The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.15
Improved stereological techniques for studying myocardial cell growth: application to external sarcolemma, T system, and intercalated disks of rabbit and rat hearts. J Ultrastruct Res (1978) 1.15
Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem J (1974) 1.13
A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides (1981) 1.13
Structure-activity relationships in bradykinin analogues. Fed Proc (1990) 1.12
Familial caudal regression anomalad and maternal diabetes. J Med Genet (1979) 1.11
Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg (1994) 1.11
The endothelial surface and responses to injury. Fed Proc (1986) 1.10
Instrument for automated synthesis of peptides. Anal Chem (1966) 1.09
cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun (1991) 1.08
Isolation and culture of pulmonary endothelial cells. Environ Health Perspect (1984) 1.08
New substrates for the radioassay of angiotensin converting enzyme of endothelial cells in culture. Tissue Cell (1978) 1.08
1H NMR studies of the solution conformations of an analogue of the C-peptide of ribonuclease A. Biochemistry (1989) 1.08
Rapid determination of the neurotoxin lolitrem B in perennial ryegrass by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1985) 1.07
Immunochemical studies on tobacco mosaic virus protein. IV. The automated solid-phase synthesis of a decapeptide of tobacco mosaic virus protein and its reaction with antibodies to the whole protein. Biochemistry (1966) 1.06
Ring 20 chromosome in a child with seizures, minor anomalies, and retardation. Arch Dis Child (1979) 1.05
Low-density lipoprotein metabolism in mice with soft tissue tumours. Biochim Biophys Acta (1984) 1.04
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
Alveolar type II cells: studies on the mode of release of lamellar bodies. Tissue Cell (1975) 1.04
H2O2-mediated cytotoxicity of rat pulmonary endothelial cells. Changes in adenosine triphosphate and purine products and effects of protective interventions. Lab Invest (1990) 1.04
Metabolism of angiotensin I in the pulmonary circulation. Biochem J (1970) 1.04
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Distribution of the DNA and the DNA-histone antigens in the nuclei of free-living and parasitic Sarcomastigophora. J Protozool (1967) 1.02
Bradykinin and inositol 1,4,5-trisphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflugers Arch (1989) 1.01
Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) (2002) 1.01
High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. Science (1989) 1.00
All-D-bradykinin and the problem of peptide antimetabolites. Nature (1965) 0.99
Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation. Free Radic Biol Med (1990) 0.99
Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol (1989) 0.99
Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature (1982) 0.99
Helix propensities of basic amino acids increase with the length of the side-chain. J Mol Biol (1996) 0.98
Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. J Clin Invest (1980) 0.98
Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J Cell Physiol (1993) 0.98
Capillaries of the adrenal cortex possess aminopeptidase A and angiotensin-converting-enzyme activities. Biochem J (1980) 0.98
Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am J Physiol (1992) 0.97
Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. J Appl Physiol (1985) (1988) 0.97
Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension (1986) 0.97
Formation of angiotensin III by angiotensin-converting enzyme. Biochem J (1976) 0.96
Importance of the carboxyl end of bradykinin and other peptides. Nature (1965) 0.96